Palisade Bio PALI
NASDAQ PALI
$2.09 +0.04 (+2.20%)
At close: Sep 4, 2026 · 4:00 PM EDT

Palisade Bio (PALI) Property, Plant & Equipment (Net) (QoQ) (2011 - 2025)

Analysis

Palisade Bio (PALI) Property, Plant & Equipment (Net) (QoQ) (2011 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Palisade Bio 440.73 Mn 315.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -50.00%
Mar 31, 2025 -33.33%
Dec 31, 2024 0.00%
Sep 30, 2024 -25.00%
Jun 30, 2024 -20.00%
Mar 31, 2024 -50.00%
Dec 31, 2023 0.00%
Sep 30, 2023 -9.09%
Jun 30, 2023 22.22%
Mar 31, 2023 -10.00%
Dec 31, 2022 -16.67%
Sep 30, 2022 500.00%
Jun 30, 2022 0.00%
Mar 31, 2022 -33.33%
Dec 31, 2021 0.00%
Sep 30, 2021 0.00%
Jun 30, 2021 -58.58%
Mar 31, 2021 44.86%
Dec 31, 2020 -66.76%
Sep 30, 2020 -30.68%